Search research articles
Contact Us
Filters
Showing results (31-40 of 84) with videos related to
Page
of 9
Sort By:
AIDS (London, England)
|
August 26, 1998
Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection
C Vidal, F García, J Romeu, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1986
Lymphocyte subpopulations in Spanish parenteral drug addicts
X Latorre, C Cuturi, J M Miro, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
January 12, 2001
[Leptospirosis. Considerations on its microbiologic diagnosis in a clinical case]
M J Echeverría, M J López de Goicoechea, J Pérez-Irezábal, et al.
AIDS (London, England)
|
August 17, 1999
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy
F García, M Plana, C Vidal, et al.
European Journal of Epidemiology
|
June 1, 1990
Seroepidemiology of measles in Catalonia (Spain) 1985-1986
L Salleras, J Vidal, J Canela, et al.
European Journal of Epidemiology
|
September 1, 1992
Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents
L Salleras, M Bruguera, J Vidal, et al.
AIDS (London, England)
|
February 24, 2001
Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/I
F Garcia, M Plana, A Soriano, et al.
Journal of Medical Virology
|
February 26, 2008
Incidence of respiratory viruses among travelers with a febrile syndrome returning from tropical and subtropical areas
M Camps, A Vilella, M A Marcos, et al.
The Journal of Hospital Infection
|
June 3, 2021
Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination
O Roca, A Pacheco, J Rodon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 2005
Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection
M Arnedo-Valero, F Garcia, C Gil, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 84) with videos related to
Sort By:
Page
of 9
AIDS (London, England)
|
August 26, 1998
Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection
C Vidal, F García, J Romeu, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1986
Lymphocyte subpopulations in Spanish parenteral drug addicts
X Latorre, C Cuturi, J M Miro, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
January 12, 2001
[Leptospirosis. Considerations on its microbiologic diagnosis in a clinical case]
M J Echeverría, M J López de Goicoechea, J Pérez-Irezábal, et al.
AIDS (London, England)
|
August 17, 1999
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy
F García, M Plana, C Vidal, et al.
European Journal of Epidemiology
|
June 1, 1990
Seroepidemiology of measles in Catalonia (Spain) 1985-1986
L Salleras, J Vidal, J Canela, et al.
European Journal of Epidemiology
|
September 1, 1992
Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents
L Salleras, M Bruguera, J Vidal, et al.
AIDS (London, England)
|
February 24, 2001
Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/I
F Garcia, M Plana, A Soriano, et al.
Journal of Medical Virology
|
February 26, 2008
Incidence of respiratory viruses among travelers with a febrile syndrome returning from tropical and subtropical areas
M Camps, A Vilella, M A Marcos, et al.
The Journal of Hospital Infection
|
June 3, 2021
Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination
O Roca, A Pacheco, J Rodon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 2005
Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection
M Arnedo-Valero, F Garcia, C Gil, et al.
Page
of 9